Trial Condition(s):

Healthy

Study to evaluate the effect of six cycles of treatment with a combined oral contraceptive (EE 0.30 mg/DRSP 3 mg) on quality of life.

Bayer Identifier:

91070

ClinicalTrials.gov Identifier:

NCT00367276

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The purpose of this study is to evaluate the effects on the quality of life and BMI of new contraceptives.

Inclusion Criteria
- Female requiring contraceptives.
 - Aged 18 to 35  if a non-smoker, aged 18 to 30 if a smoker.
 - Regular menstrual cycle (defined as duration of 28 +/- 5 days).
Exclusion Criteria
- No Contraindication for OC use

Trial Summary

Enrollment Goal
221
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Yasmin (EE30/DRSP, BAY86-5131)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design